Avax Technologies (Avax Technologies) EBIT per Share : $-0.05 (TTM As of Sep. 2008)

View and export this data going back to . Start your Free Trial

What is Avax Technologies EBIT per Share?

Avax Technologies's EBIT per Share for the three months ended in Sep. 2008 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2008 was $-0.05.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Avax Technologies's EBIT per Share or its related term are showing as below:

AVXT's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Avax Technologies's EBIT for the three months ended in Sep. 2008 was $-1.88 Mil.

Avax Technologies EBIT per Share Historical Data

The historical data trend for Avax Technologies's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avax Technologies EBIT per Share Chart

Avax Technologies Annual Data

Trend

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

EBIT per Share

Get a 7-Day Free Trial

-0.19

-0.11

-0.07

-0.09

-0.06

Avax Technologies Quarterly Data
	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08
EBIT per Share	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.01	-0.01

Avax Technologies EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Avax Technologies's EBIT per Share for the fiscal year that ended in Dec. 2007 is calculated as

	EBIT per Share		(A: Dec. 2007 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-6.693	/	118.913
=	-0.06

Avax Technologies's EBIT per Share for the quarter that ended in Sep. 2008 is calculated as

	EBIT per Share		(Q: Sep. 2008 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.878	/	141.556
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05

Avax Technologies (OTCPK:AVXT) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Avax Technologies EBIT per Share Related Terms

Thank you for viewing the detailed overview of Avax Technologies's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Avax Technologies (Avax Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avax Technologies Inc (OTCPK:AVXT) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

9200 Indian Creek Parkway, Suite 200, Overland Park, KS, USA, 66210

Website

http://www.avax-tech.com

Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.

Executives

Carl Spana	director	PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Prendergast John K A	director	ROBERTS SHERIDAN & KOTEL, 12 EAST 49TH STREET 30TH FL, NEW YORK NY 10017

Avax Technologies (Avax Technologies) Headlines

No Headlines